ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)
"Biotechnologia Acta" v. 7, no 5, 2014
https://doi.org/10.15407/biotech7.05.055
Р. 55-61, Bibliography 18, Ukrainian.
Universal Decimal classification: 547.953:615.012:665.372
OBTAINING AND CHARACTERISTIC OF CURCUMIN LIPOSOMAL FORM
State organization «Institute of Food Biotechnology and Genomics» of the National Academy of Sciences of Ukraine, Kyiv
Creation of liposomal forms of curcumin (diferuloilmetane) was investegated in the work. The methods of preparation and determination of the obtained liposomes sizes and percentage of curcumin in liposomes are given. Soybean phospholipids, egg yolk phospholipids and sunflower phospholipids were selected for preparation of “empty” liposomes and liposomes loaded curcumin: C-SPC-L (curcumin encapsulated in SPC liposomes), C-EPC-L (curcumin encapsulated in EPC liposomes) and C-SFPC-L (curcumin encapsulated in liposomes SFPC). Physical properties of different liposomes such as average size (Dl) and encapsulation efficiency (EE) were studed. Using photon correlation spectroscopy, the average size of three types of curcumin-loaded liposomes were found as Dl = 111 ± 3 nm for C-SPC-L, Dl = 98 ± 5 nm for C-EPC-L and Dl = 109 ± 5 nm for C-SFPC-L. Encapsulation efficiency showed the following values: EEC-SPC-L = 83 ± 4%, EEC-EPC-L = 82 ± 3%, and EEC-SFPC-L = 85 ± 4%.
We determined that by using the methods of freezing and thawing or sonication it was possible to isolate liposomes sized in the range 100– 120 nm. Upon that the obtained liposomal form of curcumin was stable and freeze-thaw method was optimal for liposomal form and provides a relatively high level (more than 80%) of curcumin inclusion.
Key words: curcumin, liposomes, encapsulation.
© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2014
References
1. Alexios S. Strimpacos, Ricky A. Sharma. Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials. Antiox. Redox Signal. 2008, 3(10), 511–545.
2. Preetha Anand, Sherin G. Thomas, Ajaikumar B. Kunnumakkara, Chitra Sundaram, Kuzhuvelil B. Harikumar, Bokyung Sung, Sheeja T. Tharakan, Krishna Misra, Indira K. Priyadarsini, Kallikat N. Rajasekharan, Bharat B. Aggarwal. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem. Pharmacol. 2008, V. 76, P. 1590–1611.
http://dx.doi.org/10.1016/j.bcp.2008.08.008
3. Mehmet H. Ucisik, Seta K?pc?, Bernhard Schuster, Uwe B. Sleytr. Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin. J. Nanobiotechnol. 2013, V. 11, P. 1–13.
4. Ronita De, Parag Kundu, Snehasikta Swarnakar, T. Ramamurthy, Abhijit Chowdhury, G. Balakrish Nair, Asish K. Mukhopadhyay. Antimicrobial Activity of Curcumin against Helicobacter pylori Isolates from India and during Insection in Mice. Antimicrob. Agents Chemother. 2009, 4(53), 1592–1597.
http://dx.doi.org/10.1128/AAC.01242-08
5. Claire M. Mach, Lata Mathew, Scott A. Mosley, Razelle Kurzrock, Judith A. Smith. Determination of Minimum Effective Dose and Optimal Dosing Schedule for Liposomal Curcumin in a Xenograft Human Pancreatic Cancer Model. Anticancer Res. 2009, V. 29, P. 1895–1900.
6. Songyot Anuchapreeda, Yoshinobu Fukumori, Siriporn Okonogi, Hideki Ichikawa. Preparation of Lipid Nanoemulsions Incorporating Curcumin for Cancer Therapy. J. Nanotechnol. 2012, P. 1–11.
http://dx.doi.org/10.1155/2012/270383
7. Takuro Kurita, Yuji Makino. Novel Curcumin Oral Delivery Systems. Anticancer Res. 2013, V. 33, P. 2807–2822.
8. Zhou H., Beevers C. S., Huang S. The targets of curcumin. Curr. Drug Targets. 2011, 12 (3), 332–347.
http://dx.doi.org/10.2174/138945011794815356
9. Shulga S. M. Liposomes and nanosomes: structure, properties, production. Biotechnol. acta. 2013, 6(5), 19–40. doi: 10.15407/biotech6.05.019
10. Maria Pandelidou, Konstantinos Dimas, Aristidis Georgopoulos, Sophia Hatziantiniou, Costas Demetzos. Preparation and Characterization of Lyophilised EGG PC Liposomes Incorporating Curcumin and Evaluation of Its Activity Against Colorectal Cancer Cell Lines. J. Nanosci. Nanotechnol. 2011, V. 11, P. 1259–1266.
http://dx.doi.org/10.1166/jnn.2011.3093
11. Haider Hussain. Development of liposomal curcumin for vaginal drug delivery. Thesis for the degree Master of Pharmacy, University of Troms. 2010, 73 p.
12. Santosh S. Dhule, Patrice Penfornis, Trivia Frazier, Ryan Walker, Joshua Feldman, Grace Tan, Jibao He, Alina Alb, Vijay John, Radhika Pochampally. Curcumin-loaded ?-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomed.: Nanotechnol. Biol. Med. 2012, V. 8, P. 440–451.
13. Khrobatenko O. V., Prytulska N. V., Shulga S. M. Creating and investigation of adenosine-5-triphosphate liposomal forms for oral applying. Biotechnologia Acta. 2013, 3(6), 110–115.
http://dx.doi.org/10.15407/biotech6.03.110
14. Li W., Wang S., Feng J., Xiao Y., Xue X., Zhang H., Wang Y., Liang X. Structure elucidation and NMR assignments forcurcuminoids from the rhizomes of Curcuma longa. Magn. Reson Chem. 2009, 47(10), 902–908.
http://dx.doi.org/10.1002/mrc.2478
15. Huashan Shi, Xiang Gao, Dan Li, Qiongwen Zhang, Yongsheng Wang, Yu Zheng, Lu-Lu Cai, Renming Zhong, Ao Rui, Zhiyong Li, Hao Zheng, Xiancheng Chen, Li-juan Chen. A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation. Int. J. Nanomed. 2012, V. 7, P. 2601–2611.
16. Yan Chen, Qingqing Wu, Zhenghai Zhang, Ling Yuan, Xuan Liu, Lei Zhou. Preparation of Curcumin-Loaded Liposomes and Evaluation of Their Skin Permeation and Pharmacodynamics. Molecules. 2012, V. 17, P. 5972–5987.
http://dx.doi.org/10.3390/molecules17055972
17. The use of zeta potential measurements to study sterically stabilized liposomes [Electronic resource] — www.malvern.co.uk.
18. Gubler E. V., Genkin A. A. Nonparametric yardstick of statistics using in biomedical research. Leningrad: Medicina. 1973, 144 p. (In Russian).